Characterization of the Mycobacteria PonA1 Transpeptidase Domain interaction with B-lactam antibiotics

Vol 2, 2022 - 152534
Poster
Favorite this paper
How to cite this paper?
Abstract

Tuberculosis (TB) is an infectious disease caused by the pathogen Mycobacterium tuberculosis, which is one of the major causes of death worldwide. Thus, this work aimed to evaluate the interaction of different classes of β-lactam antibiotics with the penicillin-binding protein (PBP) PonA1 from mycobacteria and then, contribute to the repositioning of antimicrobials for the tuberculosis treatment. PonA1 is involved in the peptidoglycan biosynthesis, a component of cell wall responsible for the pathogenic success of these organisms. It is well known that β-lactam can inhibit PBPs, however, characterization of their interaction with PonA1 has been vaguely reported. Thus, the first steps of this work consisted in optimizing the expression and purification conditions in the soluble fraction. Next, the enzyme was subjected to differential scan fluorimetry (DSF) analysis to identify which β-lactam disturbs the enzyme's thermal stability and the selected will be used in the inhibition assay utilizing the hydrolysis of nitrocefin.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade de São Paulo
Track
  • 1. Strategies in Drug Design
Keywords
Tuberculosis
penicillin-binding proteins
peptidoglycan
B-lactams